Axxam and leadXpro enter collaboration on a GPCR lead discovery project

Accordo tra il Socio del Cluster Axxam e LeadXpro

Axxam SpA and leadXpro AG announce today a collaboration for the discovery of novel small molecule lead compounds for a newly discovered GPCR involved in inflammatory processes.

In the collaboration, Axxam and leadXpro will combine their expertise in assay development, high throughput screening, membrane protein generation, structure determination and application of biophysical methods to investigate the interaction of small molecule ligands with challenging membrane protein drug targets to facilitate the discovery and optimization of novel lead molecules.


Clicca qui per leggere il comunicato stampa

News

Dichiarazione congiunta ERC-EIC per potenziare l’ecosistema europeo della ricerca e dell’innovazione

Leggi l'articolo

Eventi

Visione Ricerca Clinica – I driver per la competitività della ricerca clinica dalla Lombardia all’Italia

La ricerca clinica rappresenta un elemento cardine nella filiera delle Scienze della Vita, contribuendo significativamente...
Leggi l'articolo